Pharma Equity Group A/S
Pharma Equity Group A/S is a Private limited company (Ltd.) registered in Denmark under 26791413, and its current status with Danish Business Authority — CVR (Central Business Register) is active. The company was incorporated on 20 September 2002 and lists its registered address as Hørsholm, Denmark. 4 shareholders are on record for Pharma Equity Group A/S, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for Pharma Equity Group A/S, filed with Danish Business Authority — CVR (Central Business Register).
The largest of these is FINANSMANAGEMENT ApS, holding 20% — the largest recorded stake — followed by DMZ HOLDING ApS at 15%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| FINANSMANAGEMENT ApS | 20% | Danish Business Authority — CVR (Central Business Register) | |
| DMZ HOLDING ApS | 15% | Danish Business Authority — CVR (Central Business Register) | |
| N.H.L. ENTREPRISE ApS | 10% | Danish Business Authority — CVR (Central Business Register) | |
| NIELS ERIK JESPERSEN HOLDING ApS | 10% | Danish Business Authority — CVR (Central Business Register) |
Officers
5
Three of the 5 officer records shown for Pharma Equity Group A/S are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Sebastian Bo Jakobsen serves as Chief Executive Officer Of Reponex Pharmaceuticals; Lars Rosenkrantz Gundorph (appointed 2023-03-31) serves as Bestyrelsesmedlem; Lars Otto Uttenthal serves as Chief Scientific Officer. The remaining 2 records shown (Klaus Søgaard and Niels Troen) are former appointments that have since been resigned.
The register reports 60 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Pharma Equity Group A/S sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Pharma Equity Group A/S has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span Denmark, Portugal jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Pharma Equity Group A/S
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Pharma Equity Group A/S?
Four shareholders are currently on record for Pharma Equity Group A/S, filed with Danish Business Authority — CVR (Central Business Register). The largest of these is FINANSMANAGEMENT ApS, holding 20% — the largest recorded stake — followed by DMZ HOLDING ApS at 15%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Pharma Equity Group A/S's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Pharma Equity Group A/S is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Pharma Equity Group A/S have on record?
4 shareholders are shown on record for Pharma Equity Group A/S.
What is Pharma Equity Group A/S's company registration number?
Pharma Equity Group A/S's registration number is 26791413, filed with Danish Business Authority — CVR (Central Business Register) in Denmark. Its current status on the register is active.
Is Pharma Equity Group A/S still an active company?
Pharma Equity Group A/S's status on Danish Business Authority — CVR (Central Business Register) is listed as active.
When was Pharma Equity Group A/S incorporated?
Pharma Equity Group A/S was incorporated on 20 September 2002, according to Danish Business Authority — CVR (Central Business Register).
What is Pharma Equity Group A/S's registered address?
The registered address on file for Pharma Equity Group A/S is Hørsholm, Denmark.
Who are the officers/directors of Pharma Equity Group A/S?
Three of the 5 officer records shown for Pharma Equity Group A/S are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Sebastian Bo Jakobsen serves as Chief Executive Officer Of Reponex Pharmaceuticals; Lars Rosenkrantz Gundorph (appointed 2023-03-31) serves as Bestyrelsesmedlem; Lars Otto Uttenthal serves as Chief Scientific Officer. The remaining 2 records shown (Klaus Søgaard and Niels Troen) are former appointments that have since been resigned. Management authority at Pharma Equity Group A/S sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Pharma Equity Group A/S have a parent company or subsidiaries?
Pharma Equity Group A/S has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span Denmark, Portugal jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Pharma Equity Group A/S's ownership over time?
This profile reflects a point-in-time snapshot from Danish Business Authority — CVR (Central Business Register). Zavia's monitoring API can track changes to Pharma Equity Group A/S's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Pharma Equity Group A/S's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Denmark, so records like Pharma Equity Group A/S's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last synced on 28 September 2026.